Howell, Anthony <br/><br/>
Insights into the place of fulvestrant for the treatment of advanced endocrine responsive breast cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Oct 2010 
 - 4548-50 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.30.6266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Breast Neoplasms--chemistry<br/>Clinical Trials, Phase III as Topic<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Estradiol--administration & dosage<br/>Estrogen Antagonists--administration & dosage<br/>Female<br/>Fulvestrant<br/>Humans<br/>Injections, Intramuscular<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Postmenopause<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Receptors, Estrogen--analysis<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome